Autoplaque vs IM007
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Autoplaque focuses on AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images to aid in heart attack risk prediction and treatment guidance. In contrast, IM007 is an AI-powered, cloud-based platform for remote monitoring of cardiac implantable electronic devices, streamlining workflows and reducing false alerts. While both are cardiology AI tools, Autoplaque is a diagnostic imaging analysis tool, whereas IM007 is a patient management and remote monitoring platform.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Autoplaque is designed for the quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. IM007 is an AI-powered, cloud-based platform for remote cardiac monitoring, aggregating data from cardiac implantable electronic devices (CIEDs) to streamline workflows and manage alerts.
Autoplaque analyzes CT angiography images to detect and characterize coronary artery plaque and measure luminal stenoses. IM007 aggregates and analyzes data from various cardiac implantable electronic devices (CIEDs) from multiple manufacturers.
Autoplaque is a workstation-based post-processing application that includes automated vessel, plaque, and lumen segmentation, which clinicians can review and edit. IM007 provides smart workflow automation for tasks like billing, reporting, and scheduling, and offers EHR integration capabilities through a bidirectional API and integration framework.
Autoplaque offers AI-powered quantitative analysis of atherosclerotic plaque, including detection, characterization, and measurement of luminal stenoses from CT angiographic images. IM007 provides AI-driven alert management to reduce false positives, an FDA-cleared AI for ICM ECG data analysis (ILR ECG Analyzer), and predictive AI for heart failure hospitalization risk (SignalHF).